コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 within the rheumatoid lesion do not express parathyroid hormone receptor.
2 tain interacting partners such as Lfc or the parathyroid hormone receptor.
3 d receptors, closely related to secretin and parathyroid hormone receptors.
10 in modification in engineered ligands of the parathyroid hormone receptor-1, which is targeted by ost
12 inferences are surprising in the case of the parathyroid hormone receptor, a receptor that contains s
13 dds ratio 1.85, 1.18 to 2.92 for denosumab v parathyroid hormone receptor agonists and 1.56, 1.02 to
15 owed a protective effect of bisphosphonates, parathyroid hormone receptor agonists, and romosozumab c
16 the active treatment comparisons, denosumab, parathyroid hormone receptor agonists, and romosozumab w
18 receptor, the kappa-opioid receptor, and the parathyroid hormone receptor, as well as growth factor t
19 otein-coupled receptors (GPCRs), such as the parathyroid hormone receptor, can increase bone mass; ho
20 HrP(-/-)), and a constitutively active PTHrP/Parathyroid hormone Receptor expressed under the control
23 A catalytic and regulatory subunits, and the parathyroid hormone receptor in opossum kidney cells.
25 ormonal responses were not due to changes in parathyroid hormone receptor number or binding kinetics
26 receptors, the beta2-adrenoreceptor and the parathyroid hormone receptor; occupancy of the metal-bin
30 seven transmembrane-spanning receptors, the parathyroid hormone receptor (PTH1R) and frizzled (FZD),
31 f the first extracellular loop (ECL1) of the parathyroid hormone receptor (PTH1R) in the presence of
33 Agonist-mediated activation of the type 1 parathyroid hormone receptor (PTH1R) results in several
35 receptor (beta(2)AR; a type A receptor), the parathyroid hormone receptor (PTH1R; type B), and the ca
40 ement is similar to that of the ECD-1 of the parathyroid hormone receptor (PTHR), suggesting a conser
43 ed of a payload that binds and activates the parathyroid hormone receptor (PTHR1) and is linked to a
44 a conventional peptide ligand for the type 1 parathyroid hormone receptor (PTHR1) is converted from a
46 s and intracellular trafficking of the human parathyroid hormone receptor subtype 1 (hPTH1-Rc) and it